Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
High-performance liquid chromatography evaluation of lipophilicity and QSRR modeling of a series of dual DNA gyrase and topoisomerase IV inhibitors
ID
Dobričić, Vladimir
(
Author
),
ID
Savić, Jelena
(
Author
),
ID
Tomašič, Tihomir
(
Author
),
ID
Durcik, Martina
(
Author
),
ID
Zidar, Nace
(
Author
),
ID
Peterlin-Mašič, Lucija
(
Author
),
ID
Ilaš, Janez
(
Author
),
ID
Kikelj, Danijel
(
Author
),
ID
Čudina, Olivera
(
Author
)
PDF - Presentation file,
Download
(734,22 KB)
MD5: 0B776D7C0726B977BF2E6C3EEA06DD27
URL - Source URL, Visit
https://akjournals.com/view/journals/1326/36/1/article-p45.xml
Image galllery
Abstract
Bacterial DNA gyrase and topoisomerase IV control the topological state of DNA during replication and represent important antibacterial drug targets. To be successful as drug candidates, newly synthesized compounds must possess optimal lipophilicity, which enables efficient delivery to the site of action. In this study, retention behavior of twenty-three previously synthesized dual DNA gyrase and topoisomerase IV inhibitors was tested in RP-HPLC system, consisting of C8 column and acetonitrile/phosphate buffer (pH 5.5 and pH 7.4) mobile phase. logD was calculated at both pH values and the best correlation with logD was obtained for retention parameter φ0, indicating that this RP-HPLC system could be used as an alternative to the shake-flask determination of lipophilicity. Subsequent QSRR analysis revealed that intrinsic lipophilicity (logP) and molecular weight (bcutm13) have a positive, while solubility (bcutp3) has a negative influence on this retention parameter.
Language:
English
Keywords:
RP-HPLC
,
DNA gyrase and topoisomerase IV inhibitors
,
lipophilicity prediction
,
PLS
,
MLR models
,
SVM models
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
Str. 45-51
Numbering:
Vol. 36, no. 1
PID:
20.500.12556/RUL-165210
UDC:
543.544.5:615.28
ISSN on article:
2083-5736
DOI:
10.1556/1326.2022.01096
COBISS.SI-ID:
132432387
Publication date in RUL:
27.11.2024
Views:
361
Downloads:
141
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Acta Chromatographica
Shortened title:
Acta Chromatogr.
Publisher:
Institute of Chemistry, University of Silesia
ISSN:
2083-5736
COBISS.SI-ID:
4913016
Licences
License:
CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:
http://creativecommons.org/licenses/by-nc/4.0/
Description:
A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Secondary language
Language:
Slovenian
Keywords:
protibakterijska zdravila
,
zaviralci topoizomeraze IV
,
bakterijska DNA giraza
,
tekočinska kromatografija visoke ločljivosti
,
zdravila
,
tekočinska kromatografija
Projects
Funder:
MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:
451-03-68/2022-14/200161
Acronym:
MESDT
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:
BI-RS/18-19-034
Acronym:
MESTD
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back